Division of Smith & Nephew PLC
Latest From ArthroCare Corp.
Patent owners can challenge US Patent and Trial and Appeal Board's decisions on grounds the judges were not constitutionally appointed in a narrow number of cases, but they may have difficulty winning a different outcome.
The Fifth Circuit Court of Appeals has rejected former ArthroCare CEO Michael Baker’s appeal of a 20-year sentence. Baker was convicted on charges related to a $750m fraud case.
US DoJ collected more than $1bn in penalties from device manufacturers this year, chiefly on false claims and manufacturing violations. Here is a roundup and sortable table of the payouts.
Michael Gluk, who participated in a scheme to falsely inflate ArthroCare’s earnings by parking unsold merchandise with distributors, pleaded guilty to one count of conspiracy to commit wire and securities fraud after his initial conviction was overturned.
- Implantable Devices
- Radiofrequency Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Smith & Nephew PLC
- Senior Management
David Fitzgerald, Pres. & CEO
James Pacek, SVP, Global Mkts & Sales Ops, & Gen. Mgr., ENT
Jean Woloszko, MD, PhD, CTO & SVP, R&D
- Contact Info
Phone: (512) 391-3900
7000 W. William Cannon Dr.
Austin, TX 78735
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.